M. Cáceres

发表

Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios.

R. Berecz, A. Llerena, P. Dorado, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs.

R. Berecz, A. Llerena, E. Peñas-Lledó, 2006, Current drug targets.

PUBLISHED VERSION

M. Wong, J. Licinio, E. Pozo-Guisado, 2019 .

Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.

M. Wong, J. Licinio, E. Pozo-Guisado, 2005, BioTechniques.

Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.

M. Wong, J. Licinio, E. Pozo-Guisado, 2005, BioTechniques.

Schizophrenia stigma among medical and nursing undergraduates

A. Llerena, E. Peñas-Lledó, M. Cáceres, 2002, European Psychiatry.

The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions.

R. Berecz, A. Llerena, I. Degrell, 2004, Current drug targets.

Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

R. Berecz, A. Llerena, P. Dorado, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.

R. Berecz, A. Llerena, P. Dorado, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Reduced completed suicide rate in Hungary from 1990 to 2001: relation to suicide methods.

R. Berecz, A. Llerena, E. Peñas-Lledó, 2005, Journal of affective disorders.

Low frequency of CYP2D6 poor metabolizers among schizophrenia patients

A. Llerena, E. Peñas-Lledó, P. Dorado, 2007, The Pharmacogenomics Journal.

Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients

A. Llerena, E. Peñas-Lledó, M. Cáceres, 2007, European Journal of Clinical Pharmacology.

Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs

A. Llerena, E. Peñas-Lledó, P. Dorado, 2007, Clinical chemistry and laboratory medicine.

Trends in Antihypertensive Drug Use in Spanish Primary Health Care (1990- 2012)

A. Llerena, P. Dorado, J. Cobaleda, 2015 .

Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship

R. Berecz, A. Llerena, P. Dorado, 2005, Clinical chemistry and laboratory medicine.

Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5‐HTTLPR‐S) and the CYP2C9*3 allele

A. Llerena, E. Peñas-Lledó, P. Dorado, 2007, Fundamental & clinical pharmacology.

Reproducibility over time of the urinary diclofenac/4′-OH diclofenac ratio among differentCYP2C9 genotypes

R. Berecz, A. Llerena, P. Dorado, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers

A. Llerena, V. Ribeiro, P. Dorado, 2008, European Journal of Clinical Pharmacology.